Riskpilot← Back to searchSign inGet full accessC- ApS
APSActiveCVR 37445894Margrethevej 20Research and experimental development on natural sciences and engineering · NACE 7210Est. 20161 employees
Revenue 2025
DKK 936K
+8% vs 2024
EBITDA margin
22.6%
+64% vs 2024
Equity ratio
94.5%
Financial strength
Net profit 2025
DKK 730K
-13% vs 2024
| Revenue | DKK 936K | +8% |
| EBITDA | DKK 211K | +64% |
| Net profit | DKK 730K | -13% |
| Total assets | DKK 5,8M | +19% |
| Equity | DKK 5,4M | +16% |
| Employees | 1 | — |
Legal name
C- ApS
CVR number
37445894
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. februar 2016
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at levere konsulentydelser indenfor biotek, lægemidler, sundhed og sygdom samt relateret virksomhed efter direktionens skøn.
Address
Margrethevej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 387 | 406 | 946 | 744 | 956 | 206 | 1.506 | 992 | 870 | 936 |
| Staff expenses | -0 | -320 | -410 | -410 | -61 | -64 | -415 | -500 | -742 | -725 |
| EBITDA | 387 | 86 | 537 | 334 | 895 | 142 | 1.092 | 492 | 129 | 211 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 387 | 86 | 537 | 334 | 895 | 142 | 1.092 | 492 | 129 | 211 |
| Net financials | -2 | -1 | -85 | 213 | 657 | 442 | -1.455 | 1.092 | 952 | 725 |
| Profit before tax | 385 | 85 | 451 | 547 | 1.552 | 584 | -363 | 1.584 | 1.081 | 936 |
| Tax | 85 | 19 | 99 | 120 | 289 | 129 | -0 | 269 | 238 | 206 |
| Net profit | 300 | 66 | 352 | 426 | 1.262 | 455 | -363 | 1.315 | 843 | 730 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 482 | 623 | 979 | 1.688 | 3.201 | 3.368 | 2.974 | 4.117 | 4.842 | 5.752 |
| Equity | 350 | 417 | 769 | 1.195 | 2.457 | 2.912 | 2.549 | 3.864 | 4.707 | 5.437 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 132 | 207 | 210 | 490 | 743 | 456 | 425 | 252 | 135 | 315 |
| Total debt | 132 | 207 | 210 | 490 | 743 | 456 | 425 | 252 | 135 | 315 |
EBITDA margin
22.6%
This company
15.8%
Market median
+43% vs market
20162025
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
20162025
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20162025
Net profit margin
78.0%
This company
8.1%
Market median
+863% vs market
20162025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20162025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-02-12 – 2016-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C- ApS 
Tissue-Link ApSBoard members of C- ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|